Mechanisms modifying atherosclerotic disease — from lipids to vascular biology
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 147, S3-S10
- https://doi.org/10.1016/s0021-9150(99)00249-x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Angiographic progression of coronary artery disease and the development of myocardial infarctionPublished by Elsevier ,2004
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Comparative effect of pravastatin and simvastatin on platelet-thrombus formation in hypercholesterolemic coronary patientsJournal of the American College of Cardiology, 1996
- Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiographyPublished by Elsevier ,1992
- Lovastatin Therapy in Hypercholesterolemia: Effect on Fibrinogen, Hemorrheologic Parameters, Platelet Activity, and Red Blood Cell MorphologyThe Journal of Clinical Pharmacology, 1991
- Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytesPharmacological Research, 1991
- Hemorheologic and Coagulative Pattern in Hypercholesterolemic Subjects Treated with Lipid-Lowering DrugsAngiology, 1991